Other
68Ga-DOTATOC PET/CT
68Ga-DOTATOC PET/CT is an intervention with 6 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DIAGNOSTIC TEST
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
1(17%)
Results Posted
50%(2 trials)
Phase Distribution
Ph not_applicable
1
17%
Ph phase_1
1
17%
Ph phase_2
2
33%
Phase Distribution
1
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
2(50.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
6
all time
Status Distribution
Active(1)
Completed(4)
Other(1)
Detailed Status
Completed4
Active, not recruiting1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
1
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 11 (25.0%)
Phase 22 (50.0%)
N/A1 (25.0%)
Trials by Status
completed467%
active_not_recruiting117%
unknown117%
Recent Activity
1 active trials
Showing 5 of 6
active_not_recruiting
DOTATOC PET/CT for Imaging NET Patients
NCT03583528
completednot_applicable
Somatostatin Receptor Imaging in Acute Myocarditis and Cardiac Sarcoidosis
NCT04206163
completedphase_2
Early Feasibility Study of Somatostatin Receptors PET Imaging for the Diagnosis of Infective Endocarditis
NCT05183555
completedphase_1
Safety of 68Ga-DOTA-tyr3-Octreotide PET in Diagnosis of Solid Tumors
NCT01619865
unknown
Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging
NCT04017104
Clinical Trials (6)
Showing 6 of 6 trials
NCT03583528
DOTATOC PET/CT for Imaging NET Patients
NCT04206163Not Applicable
Somatostatin Receptor Imaging in Acute Myocarditis and Cardiac Sarcoidosis
NCT05183555Phase 2
Early Feasibility Study of Somatostatin Receptors PET Imaging for the Diagnosis of Infective Endocarditis
NCT01619865Phase 1
Safety of 68Ga-DOTA-tyr3-Octreotide PET in Diagnosis of Solid Tumors
NCT04017104
Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging
NCT02441062Phase 2
Impact of Ga-68 DOTATOC PET-CT Imaging in Management of Neuroendocrine Tumors
All 6 trials loaded
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 6